Melanoma News and Research

Latest Melanoma News and Research

Preclinical studies show bladder cancers, mesotheliomas respond to treatment with ADI-PEG 20

Scientists from academic institutions reported at the 2013 annual American Association for Cancer Research meeting, results from preclinical studies which showed that certain bladder cancers and mesotheliomas have metabolic changes and are more likely to respond to treatment with ADI-PEG 20 (pegylated arginine deiminase) if they are deficient in the enzyme, argininosuccinate synthetase.

18 Apr 2013

Research: Transcription factors regulating oxygen levels in blood play a role in melanoma metastases

Researchers at the University of North Carolina have discovered that transcription factors regulating the levels of oxygen in the blood also play a role in the spread of the skin cancer melanoma.

17 Apr 2013

Melanoma patients with lower educational background more likely to die of the disease

There are socioeconomic differences in Sweden in survival amongst people with malignant skin melanoma, according to a study published in the European Journal of Cancer.

17 Apr 2013

MRA awards $9M grant to scientists for exploring new treatments and cures for melanoma

The Melanoma Research Alliance (MRA), the largest private funder of melanoma research, today announced grant awards exceeding $9.6 million to 49 scientists at leading academic institutions around the world for investigating new treatments and cures for melanoma.

16 Apr 2013

Navidea presents Phase 3 Lymphoseek study results at international symposium in Athens

Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that a presentation of results from its Phase 3 clinical trial of Lymphoseek (technetium 99m tilmanocept) Injection in patients with head and neck squamous cell carcinoma received the 1st Investigator Award at the 2nd InternationaI Symposium on Thoracic and Upper Aerodigestive Malignancies.

15 Apr 2013

Challenges in changing behaviors, factors to reduce cancer risk continue

An annual report from the American Cancer Society finds continuing challenges in changing behaviors and risk factors in order to reduce suffering and death from cancer.

12 Apr 2013

UT MD Anderson scientist receives AACR-CRI Lloyd J. Old Award in Cancer Immunology

The scientist whose discoveries led to the first drug approved for metastatic melanoma by "treating the immune system, not the cancer," also is the first to receive the AACR-CRI Lloyd J. Old Award in Cancer Immunology.

12 Apr 2013

Omeros' GPCR platform unlocks new drug targets against multiple sclerosis

Omeros Corporation today announced positive data in the most commonly used model for studying the clinical and pathological features of multiple sclerosis (MS), further advancing its development program of GPR17-targeting compounds for the treatment of MS. Compounds previously discovered by Omeros that inhibit GPR17, an orphan G protein-coupled receptor (GPCR) unlocked by Omeros, significantly improved function from experimental autoimmune encephalomyelitis (EAE) in mice.

11 Apr 2013

Data on PV-10 combination therapy presented at AACR Annual Meeting

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, presented data on PV-10 combination therapy today at the American Association for Cancer Research Annual Meeting in Washington, DC.

11 Apr 2013

Research opens new avenue for treatment of melanoma

For the first time, scientists have demonstrated the mechanism of action of gossypin, a naturally-occurring substance found in fruits and vegetables, as a treatment for melanoma, which causes the majority of deaths from skin cancer.

11 Apr 2013

Immunotherapy and epigenetics advancements presented by Ludwig at the American Association for Cancer Research

A dozen Ludwig scientists from around the world presented the latest advancements in basic and clinical cancer research at this week’s American Association for Cancer Research (AACR) Annual Meeting 2013. Progress in immunotherapy and epigenetics led the program with important diagnostic and treatment implications for emerging cancer therapy.

10 Apr 2013

Research shows UNC1062 blocks Mer survival signaling in melanoma cells

Collaborative research presented by the University of Colorado Cancer Center, the University of North Carolina at Chapel Hill, Harvard Medical School and the University of Pittsburgh, at the American Association for Cancer Research Annual Conference, shows that the protein receptor Mer is overexpressed in melanoma and that the investigational drug UNC1062 blocks Mer survival signaling in these cells, killing them.

10 Apr 2013

New immunotherapies are seldom developed for childhood cancer

More often than not, cancer immunotherapies that work in adults are used in modified ways in children. Seldom are new therapies developed just for children, primarily because of the small number of pediatric patients relative to the adult cancer patient population.

9 Apr 2013

New study looks at increasing rates of melanoma in US children

With springtime temperatures and warm weather approaching, the inclination to spend time outdoors is a strong one - especially for children who have been cooped up all winter.

9 Apr 2013

GE Healthcare releases next-generation sequencing assay for use in clinical trials

GE Healthcare announced today that Clarient Diagnostic Services, Inc., a GE Healthcare company, will begin offering a next-generation sequencing assay focused on solid tumor targets for use in clinical trials.

8 Apr 2013

Nektar Therapeutics presents positive results for NKTR-214 at AACR Annual Meeting

Nektar Therapeutics today presented positive preclinical data for NKTR-214, a novel cancer immunotherapy which targets the IL-2 receptor complex, at the 2013 American Association for Cancer Research Annual Meeting.

8 Apr 2013

Individualized genomic analysis allows for tailored cancer treatment, new drug research

Just like a massive iceberg jutting out of the ocean, many of cancer's genetic underpinnings remain hidden under the surface, impossible to predict or map from above.

6 Apr 2013

Wistar scientists describe mechanics of oncogene-induced senescence

Researchers from The Wistar Institute explain a new molecular mechanism behind the phenomenon of oncogene-induced senescence. By depriving the cell of the ability to make new nucleotides-the building blocks of DNA molecules-cells can suppress cancer development by forcing a damaged cell into a senescent state, where the cell remains alive yet cannot reproduce.

5 Apr 2013

Illumina releases TruSight Tumor for NGS-based somatic variant detection in solid tumors

Illumina, Inc. today announced the next product in its TruSight line of content sets, TruSight Tumor, for NGS-based somatic variant detection in solid tumors.

From Illumina, Inc. 4 Apr 2013

New Jersey bans minors under age of 17 years old from using indoor tanning salons

New Jersey sent a strong message to young people that indoor tanning salons can be dangerous to their health. New Jersey has passed a law that bans minors under the age of 17 years old from using indoor tanning devices.

3 Apr 2013

Melanoma News and Research

Latest Melanoma News and Research

Preclinical studies show bladder cancers, mesotheliomas respond to treatment with ADI-PEG 20

Research: Transcription factors regulating oxygen levels in blood play a role in melanoma metastases

Melanoma patients with lower educational background more likely to die of the disease

MRA awards $9M grant to scientists for exploring new treatments and cures for melanoma

Navidea presents Phase 3 Lymphoseek study results at international symposium in Athens

Challenges in changing behaviors, factors to reduce cancer risk continue

UT MD Anderson scientist receives AACR-CRI Lloyd J. Old Award in Cancer Immunology

Omeros' GPCR platform unlocks new drug targets against multiple sclerosis

Data on PV-10 combination therapy presented at AACR Annual Meeting

Research opens new avenue for treatment of melanoma

Immunotherapy and epigenetics advancements presented by Ludwig at the American Association for Cancer Research

Research shows UNC1062 blocks Mer survival signaling in melanoma cells

New immunotherapies are seldom developed for childhood cancer

New study looks at increasing rates of melanoma in US children

GE Healthcare releases next-generation sequencing assay for use in clinical trials

Nektar Therapeutics presents positive results for NKTR-214 at AACR Annual Meeting

Individualized genomic analysis allows for tailored cancer treatment, new drug research

Wistar scientists describe mechanics of oncogene-induced senescence

Illumina releases TruSight Tumor for NGS-based somatic variant detection in solid tumors

New Jersey bans minors under age of 17 years old from using indoor tanning salons

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Melanoma News and Research

Latest Melanoma News and Research

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in